Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
BIO.B
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.45B
Close$
Share Statistics
| Market cap | $8.45 Billion |
|---|---|
| Enterprise Value | $9.07 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 2.46% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | 113.33% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.5 |
| Enterprise Value to EBIT | -8.73 |
| Enterprise Value to Net Income | 53 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bio-Rad Laboratories Inc.
CEO: Norman Schwartz